Live Breaking News & Updates on Stoke Therapeutics Company Profile

Stay updated with breaking news from Stoke therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stoke Therapeutics (NASDAQ:STOK) Shares Down 4%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price dropped 4% during mid-day trading on Tuesday . The stock traded as low as $13.75 and last traded at $13.83. Approximately 166,733 shares traded hands during trading, a decline of 82% from the average daily volume of 922,683 shares. The stock had previously closed at […] ....

United States , Jonathan Allan , Cantor Fitzgerald , Stoke Therapeutics Inc , Dorsey Whitney Trust , Canaccord Genuity Group , York Mellon Corp , Jpmorgan Chase Co , Securities Exchange Commission , Needham Company , Pricet Rowe Associates Inc , Board Of Administration Florida Retirement System , Stoke Therapeutics Company Profile , Stoke Therapeutics , Get Free Report , Genuity Group , Exchange Commission , General Counsel Jonathan Allan , New York Mellon Corp , Financial Markets , Florida Retirement System , Whitney Trust , Stoke Therapeutics Daily ,

Stoke Therapeutics (NASDAQ:STOK) Trading Up 7.2%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price was up 7.2% during trading on Wednesday . The company traded as high as $16.49 and last traded at $16.46. Approximately 277,244 shares changed hands during trading, a decline of 70% from the average daily volume of 932,838 shares. The stock had previously closed at […] ....

United States , Stephenj Tulipano , Needham Company , Vanguard Group Inc , Securities Exchange Commission , Stoke Therapeutics Company Profile , Capital Partners , Cantor Fitzgerald , Stoke Therapeutics Inc , Redmile Group , Jpmorgan Chase Co , Stoke Therapeutics , Get Free Report , Exchange Commission , Stoke Therapeutics Daily ,

Canaccord Genuity Group Lowers Stoke Therapeutics (NASDAQ:STOK) Price Target to $20.00

Canaccord Genuity Group Lowers Stoke Therapeutics (NASDAQ:STOK) Price Target to $20.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Jonathan Allan , Board Of Administration Florida Retirement System , York Mellon Corp , Sherbrooke Park Advisers , Stoke Therapeutics Company Profile , Canaccord Genuity Group , Dorsey Whitney Trust , Stoke Therapeutics Inc , Jpmorgan Chase Co , Needham Company , Stoke Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , General Counsel Jonathan Allan , Skorpios Trust , New York Mellon Corp , Financial Markets , Florida Retirement System , Whitney Trust , Stoke Therapeutics Daily ,

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc. (NASDAQ:STOK)

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc. (NASDAQ:STOK)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Sg Americas Securities , Stoke Therapeutics Inc , Jpmorgan Chase Co , Stoke Therapeutics Company Profile , Mirae Asset Global Investments Co , Securities Exchange Commission , Dorsey Whitney Trust , Canaccord Genuity Group , Needham Company , York Mellon Corp , Stoke Therapeutics , Free Report , Stoke Therapeutic , Genuity Group , Therapeutics Trading Down , Get Free Report , New York Mellon Corp , Asset Global Investments , Whitney Trust , Trexquant Investment , Exchange Commission , Skorpios Trust , Stoke Therapeutics Daily ,

Stoke Therapeutics, Inc. (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0.17 Per Share

Stoke Therapeutics, Inc. (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0.17 Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Stephenj Tulipano , Stoke Therapeutics Inc , Stoke Therapeutics Company Profile , Jpmorgan Chase Co , Cantor Fitzgerald , Needham Company , Canaccord Genuity Group , Capital Partners , Mirae Asset Global Investments Co , Securities Exchange Commission , Stoke Therapeutics , Free Report , Stoke Therapeutic , Get Free Report , Therapeutics Stock Down , Exchange Commission , Skorpios Trust , Asset Global Investments , Trexquant Investment , Stoke Therapeutics Daily ,